Detalhe da pesquisa
1.
PD-1/PD-L1 expression and interaction by automated quantitative immunofluorescent analysis show adverse prognostic impact in patients with diffuse large B-cell lymphoma having T-cell infiltration: a study from the International DLBCL Consortium Program.
Mod Pathol
; 32(6): 741-754, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30666052
2.
MDS-associated somatic mutations and clonal hematopoiesis are common in idiopathic cytopenias of undetermined significance.
Blood
; 126(21): 2355-61, 2015 Nov 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-26429975
3.
Multimarker scores of Th1 and Th2 immune cellular profiles in peripheral blood predict response and immune related toxicity with CTLA4 blockade and IFNα in melanoma.
Transl Oncol
; 14(3): 101014, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33450703
4.
Clinical Features and Multiplatform Molecular Analysis Assist in Understanding Patient Response to Anti-PD-1/PD-L1 in Renal Cell Carcinoma.
Cancers (Basel)
; 13(6)2021 Mar 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-33806963
5.
MEK activation modulates glycolysis and supports suppressive myeloid cells in TNBC.
JCI Insight
; 5(15)2020 08 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32634121
6.
Improved Prognosis and Increased Tumor-Infiltrating Lymphocytes in Patients Who Have SCLC With Neurologic Paraneoplastic Syndromes.
J Thorac Oncol
; 14(11): 1970-1981, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31201935
7.
Quantitative Spatial Profiling of PD-1/PD-L1 Interaction and HLA-DR/IDO-1 Predicts Improved Outcomes of Anti-PD-1 Therapies in Metastatic Melanoma.
Clin Cancer Res
; 24(21): 5250-5260, 2018 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30021908
8.
ASXL1 frameshift mutations drive inferior outcomes in CMML without negative impact in MDS.
Blood Cancer J
; 7(12): 633, 2017 11 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-29176559